INHIBITION OF HUMAN ERYTHROCYTE OROTIDYLATE DECARBOXYLASE

被引:29
作者
BROWN, GK
OSULLIVAN, WJ
机构
[1] UNIV SYDNEY,DEPT MED,SYDNEY 2006,NEW S WALES,AUSTRALIA
[2] UNIV NEW S WALES,SCH BIOCHEM,KENSINGTON 2033,NEW S WALES,AUSTRALIA
关键词
D O I
10.1016/0006-2952(77)90171-X
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:1947 / 1950
页数:4
相关论文
共 18 条
[1]  
APPEL SH, 1968, J BIOL CHEM, V243, P3924
[2]  
BEARDMORE TD, 1971, J LAB CLIN MED, V78, P696
[3]  
BLAIR DG, 1961, J BIOL CHEM, V236, P2503
[4]  
BROWN GK, 1975, J BIOL CHEM, V250, P7352
[5]  
CARDOSO SS, 1961, CANCER RES, V21, P1551
[6]  
CREASEY WA, 1961, J BIOL CHEM, V236, P2058
[7]   THE DETERMINATION OF ENZYME INHIBITOR CONSTANTS [J].
DIXON, M .
BIOCHEMICAL JOURNAL, 1953, 55 (01) :170-171
[8]   METABOLIC STUDIES OF ALLOPURINOL AN INHIBITOR OF XANTHINE OXIDASE [J].
ELION, GB ;
KOVENSKY, A ;
HITCHING.GH ;
METZ, E ;
RUNDLES, RW .
BIOCHEMICAL PHARMACOLOGY, 1966, 15 (07) :863-&
[9]  
FALLON NJ, 1961, J CLIN INVEST, V40, P1906
[10]   STUDIES ON COORDINATE ACTIVITY AND LABILITY OF OROTIDYLATE PHOSPHORIBOSYLTRANSFERASE AND DECARBOXYLASE IN HUMAN ERYTHROCYTES, AND EFFECTS OF ALLOPURINOL ADMINISTRATION [J].
FOX, RM ;
WOOD, MH ;
OSULLIVA.WJ .
JOURNAL OF CLINICAL INVESTIGATION, 1971, 50 (05) :1050-&